Skip to main content
Caplight Logo









CCRM

CCRM

Torontoccrm.ca

Overview

CCRM is a global, public-private partnership and investment firm that accelerates the commercialization of regenerative medicine-based technologies and cell and gene therapies by launching and scaling early-stage companies.

Year Founded

2011

Portfolio Companies

2

Website

ccrm.ca

Investments

CCRM investments
CompanyDateStageLead
Notch TherapeuticsFeb 2021Series ACo-investor
ExCellTheraJun 2015AcceleratorCo-investor

Key People

Peter Zandstra

Co-Founder and Chief Scientific Officer

Erik K.

Investment Manager

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is CCRM based?

CCRM is headquartered in Toronto, Canada.

When was CCRM founded?

CCRM was founded in 2011.

How many portfolio companies does CCRM have?

CCRM has 2 portfolio companies in Caplight's dataset.

What are some companies in CCRM's portfolio?

Portfolio companies visible on Caplight include Notch Therapeutics, ExCellThera.

What was CCRM's most recent investment shown here?

CCRM's most recent investment in this portfolio sample was in Notch Therapeutics in 2021.

What sectors does CCRM focus on?

CCRM focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.

What company stages does CCRM focus on?

CCRM typically invests at the Early stage.

Firmographic Details

HeadquartersToronto
Year Founded2011

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?